α-Linolenic acid, a nutraceutical with pleiotropic properties that targets endogenous neuroprotective pathways to protect against organophosphate nerve agent-induced neuropathology

Molecules

Volumn 20, Issue 11, 2015, Pages 20355-20380

  Piermartiri, Tetsade ^a   Pan, Hongna ^a   Figueiredo, Taiza H ^a   Marini, Ann M ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

BDNF; MTOR; Natural product; Neuroprotection; Neurorestoration; Nutraceutical; Pleiotropic; Rat; Soman; linolenic acid

Indexed keywords

ANTIDEPRESSANT AGENT; LINOLENIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NERVE GAS; NEUROPROTECTIVE AGENT; ORGANOPHOSPHATE;

ANIMAL; ANIMAL MODEL; BRAIN; CHEMICALLY INDUCED; COGNITION; COGNITION DISORDERS; DIETARY SUPPLEMENT; DRUG EFFECTS; HUMAN; METABOLISM; NERVOUS SYSTEM DISEASES; NEURODEGENERATIVE DISEASES; NEUROPATHOLOGY; NEUROPROTECTION; SIGNAL TRANSDUCTION;

ALPHA-LINOLENIC ACID; ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN; COGNITION; COGNITION DISORDERS; DIETARY SUPPLEMENTS; HUMANS; MODELS, ANIMAL; NERVE AGENTS; NERVOUS SYSTEM DISEASES; NEURODEGENERATIVE DISEASES; NEUROPATHOLOGY; NEUROPROTECTION; NEUROPROTECTIVE AGENTS; ORGANOPHOSPHATES; RECEPTORS, N-METHYL-D-ASPARTATE; SIGNAL TRANSDUCTION;

EID: 84949988415     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules201119698     Document Type: Review

References (221)

1. Tinoco, J. Dietary requirements and functions of α-linolenic acid in animals. Prog. Lipid Res. 1982, 21, 1-45. [Cross Ref]
2. Crupi, R.; Marino, A.; Cuzzocrea, S. N-3 Fatty acids: Role in neurogenesis and neuroplasticity. Curr. Med. Chem. 2013, 20, 2953-2963. [Cross Ref] [Pub Med]
3. Blondeau, N.; Nguemeni, C.; Debruyne, D.N.; Piens, M.; Wu, X.; Pan, H.; Hu, X.; Gandin, C.; Lipsky, R.H.; Plumier, J.C.; et al. Subchronic α-linolenic acid treatment enhances brain plasticity and exerts an antidepressant effect: A versatile potential therapy for stroke. Neuropsychopharmacology 2009, 34, 2548-2559. [Cross Ref]
4. Piermartiri, T.C.; Pan, H.; Chen, J.; McDonough, J.; Grunberg, N.; Apland, J.P.; Marini, A.M. α-Linolenic acid-induced increase in neurogenesis is a key factor in the improvement in the passive avoidance task after soman exposure. Neuromol. Med. 2015, 17, 251-269. [Cross Ref] [Pub Med]
5. Cunnane, S.C.; Ganguli, S.; Menard, C.; Liede, A.C.; Hamadeh, M.J.; Chen, Z.Y.;Wolever, T.M.; Jenkins, D.J. High α-linolenic acid flaxseed (Linum usitatissimum): Some nutritional properties in humans. Br. J. Nutr. 1993, 69, 443-453. [Cross Ref] [Pub Med]
6. Kim, K.B.; Nam, Y.A.; Kim, H.S.; Hayes, A.W.; Lee, B.M. α-Linolenic acid: Nutraceutical, pharmacological and toxicological evaluation. Food Chem. Toxicol. 2014, 70, 163-178. [Cross Ref] [Pub Med]
7. Cocchi, M.; Pignatti, C.; Carpigiani, M.; Tarozzi, G.; Turchetto, E. Effect of C 18:3 (n-3) dietary supplementation on the fatty acid composition of the rat brain. Acta Vitaminol. Enzymol. 1984, 6, 151-156. [Pub Med]
8. Plourde, M.; Cunnane, S.C. Extremely limited synthesis of long chain polyunsaturates in adults: Implications for their dietary essentiality and use as supplements. Appl. Physiol. Nutr. Metab. 2007, 32, 619-634. [Cross Ref] [Pub Med]
9. Lin, Y.H.; Salem, N., Jr. Whole body distribution of deuterated linolenic and α-linolenic acids and their metabolites in the rat. J. Lipid Res. 2007, 48, 2709-2724. [Cross Ref] [Pub Med]
10. Emken, E. Human studies using isotope labeled-fatty acids: Answered and unanswered questions. J. Oleo Sci. 2013, 62, 245-255. [Cross Ref] [Pub Med]
11. Anding, R.H.; Hwang, D.H. Effects of dietary linolenate on the fatty acid composition of brain lipids in rats. Lipids 1986, 21, 697-701. [Cross Ref] [Pub Med]
12. Yamamoto, N.; Saitoh, M.; Moriuchi, A.; Nomura, M.; Okuyama, H. Effect of dietary α-linolenate/linoleate balance on brain lipid compositions and learning ability of rats. J. Lipid Res. 1987, 28, 144-151. [Pub Med]
13. Bourre, J.M.; Francois, M.; Youyou, A.; Dumont, O.; Piciotti, M.; Pascal, G.; Durand, G. The effects of dietary α-linolenic acid on the composition of nerve membranes, enzymatic activity, amplitude of electrophysiological parameters, resistance to poisons and performance of learning tasks in rats. J. Nutr. 1989, 119, 1880-1892. [Pub Med]
14. Blondeau, N.; Lipsky, R.H.; Bourourou, M.; Duncan, M.W.; Gorelick, P.B.; Marini, A.M. α-linolenic acid: An omega-3 fatty acid with neuroprotectivge properties-Ready for use in the stroke clinic? Bio Med. Res. Int. 2015, 2015, 519830. [Cross Ref] [Pub Med]
15. Novelli, A.; Reilly, J.A.; Lysko, P.G.; Henneberry, R.C. Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res. 1988, 451, 205-212. [Cross Ref]
16. Lipsky, R.H.; Xu, K.; Zhu, D.; Kelly, C.; Terhakopian, A.; Novelli, A.; Marini, A.M. NF-κB is a critical determinant for NMDA receptor-mediated neuroprotection. J. Neurochem. 2001, 78, 254-264. [Cross Ref] [Pub Med]
17. Choi, D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988, 1, 623-634. [Cross Ref]
18. Parsons, M.P.; Raymond, L.A. Extrasynaptic NMDA receptor involvement in central nervous system disorders. Neuron 2014, 82, 279-293. [Cross Ref] [Pub Med]
19. Lauritzen, I.; Blondeau, N.; Heurteaux, C.; Widmann, C.; Romey, G.; Lazdunski, M. Polyunsaturated fatty acids are potent neuroprotectors. EMBO J. 2000, 19, 1784-1793. [Cross Ref] [Pub Med]
20. Blondeau, N.;Widmann, C.; Lazdunski, M.; Heurteaux, C. Activation of the nuclear factor-κB is a key event in brain tolerance. J. Neurosci. 2001, 21, 4668-4677. [Pub Med]
21. Pan, H.; Hu, X.Z.; Jacobowitz, D.M.; Chen, C.; McDonough, J.; van Shura, K.; Lyman, M.; Marini, A.M. A-linolenicacid is a potent neuroprotective agent against soman-induced neuropathology. Neurotoxicology 2012, 33, 1219-1229. [Cross Ref] [Pub Med]
22. Marini, A.M.; Jiang, X.; Wu, X.; Pan, H.; Guo, Z.; Mattson, M.P.; Blondeau, N.; Novelli, A.; Lipsky, R.H. Preconditioning and neurotrophins: A model for brain adaptation to seizures, ischemia and other stressful stimuli. Amino Acids 2007, 32, 299-304. [Cross Ref] [Pub Med]
23. Mattson, M.P.; Culmsee, C.; Yu, Z.; Camandola, S. Roles of nuclear factor κB in neuronal survival and plasticity. J. Neurochem. 2000, 74, 443-456. [Cross Ref] [Pub Med]
24. Meffert, M.K.; Baltimore, D. Physiological functions for brain NF-κB. Trends Neurosci. 2005, 28, 37-43. [Cross Ref] [Pub Med]
25. Mattson, M.P.; Meffert, M.K. Roles for NF-κB in nerve cell survival, plasticity, and disease. Cell Death Differ. 2006, 13, 852-860. [Cross Ref] [Pub Med]
26. Boersma, M.C.; Dresselhaus, E.C.; de Biase, L.M.; Mihalas, A.B.; Bergles, D.E.; Meffert, M.K. A requirement for nuclear factor-κB in developmental and plasticity-associated synaptogenesis. J. Neurosci. 2011, 31, 5414-5425. [Cross Ref] [Pub Med]
27. Lang-Lazdunski, L.; Blondeau, N.; Jarretou, G.; Lazdunski, M.; Heurteaux, C. Linolenic acid prevents neuronal cell death and paraplegia after transient spinal cord ischemia in rats. J. Vasc. Surg. 2003, 38, 564-575. [Cross Ref]
28. + channel involved in neuroprotection and general anesthesia. EMBO J. 2004, 23, 2684-2695. [Cross Ref] [Pub Med]
29. Heurteaux, C.; Laigle, C.; Blondeau, N.; Jarretou, G.; Lazdunski, M. α-linolenic acid and riluzole treatment confer cerebral protection and improve survival after focal brain ischemia. Neuroscience 2006, 137, 241-251. [Cross Ref] [Pub Med]
30. Nguemeni, C.; Delplanque, B.; Rovère, C.; Simon-Rousseau, N.; Gandin, C.; Agnani, G.; Nahon, J.L.; Heurteaux, C.; Blondeau, N. Dietary supplementation of α-linolenic acid in an enriched rapeseed oil diet protects from stroke. Pharmacol. Res. 2010, 61, 226-233. [Cross Ref] [Pub Med]
31. Thiermann, H.; Szinicz, L.; Eyer, P.; Felgenhauer, N.; Zilker, T.; Worek, F. Lessons to be learnt from organophosphorus pesticide poisoning for the treatment of nerve agent poisoning. Toxicology 2007, 233, 145-154. [Cross Ref] [Pub Med]
32. Okumura, T.; Takasu, N.; Ishimatsu, S.; Miyanoki, S.; Mitsuhashi, A.; Kumada, K.; Tanaka, K.; Hinohara, S. Report on 640 victims of the Tokyo subway sarin attack. Ann. Emerg. Med. 1996, 28, 129-135. [Cross Ref]
33. Nozaki, H.; Aikawa, N.; Shinozawa, Y.; Hori, S.; Fujishima, S.; Takuma, K.; Sagoh, M. Sarin poisoning in Tokyo subway. Lancet 1995, 345, 980-981. [Pub Med]
34. Szinicz, L. History of chemical and biological warfare agents. Toxicology 2005, 214, 167-181. [Cross Ref] [Pub Med]
35. Dolgin, E. Syrian gas attack reinforces need for better anti-sarin drugs. Nat. Med. 2013, 19, 1194-1195. [Cross Ref] [Pub Med]
36. Millard, C.B.; Kryger, G.; Ordentlich, A.; Greenblatt, H.M.; Harel, M.; Raves, M.L.; Segall, Y.; Barak, D.; Shafferman, A.; Silman, I.; et al. Crystal structures of aged phosphonylated acetylcholinesterase: Nerve agent reaction products at the atomic level. Biochemistry 1999, 38, 7032-7039. [Cross Ref] [Pub Med]
37. Wiener, S.W.; Hoffman, R.S. Nerve agents: A comprehensive review. J. Intensive Care Med. 2004, 19, 22-37. [Cross Ref] [Pub Med]
38. Olney, J.W.; de Gubareff, T.; Labruyere, J. Seizure-related brain damage induced by cholinergic agents. Nature 1983, 301, 520-522. [Cross Ref] [Pub Med]
39. Pazdernik, T.L.; Cross, R.S.; Giesler, M.; Samson, F.E.; McDonough, J., Jr. Delayed effect of soman: Brain glucose use and pathology. Neurotoxicology 1985, 6, 61-70. [Pub Med]
40. Shih, T.-M.; Duniho, S.M.; McDonough, J.H. Control of nerve agent-induced seizures is critical for neuroprotection and survival. Toxicol. Appl. Pharmacol. 2003, 188, 69-80.
41. Aroniadou-Anderjaska, V.; Figueiredo, T.H.; Apland, J.P.; Qashu, F.; Braga, M.F.M. Primary brain targets of nerve agents: The role of the amygdala in comparison to the hippocampus. Neurotoxicology 2009, 30, 772-776. [Cross Ref] [Pub Med]
42. Harrison, P.K.; Sheridan, R.D.; Green, A.C.; Scott, I.R.; Tattersall, J.E. A Guinea pig hippocampal slice model of organophosphate-induced seizure activity. J. Pharmacol. Exp. Ther. 2004, 310, 678-686. [Cross Ref] [Pub Med]
43. McDonough, J.H., Jr.; Shih, T.M. Pharmacological modulation of soman-induced seizures. Neurosci. Biobehav. Rev. 1993, 17, 203-215. [Cross Ref]
44. Lallement, G.; Carpentier, P.; Pernot-Marino, I.; Baubichon, D.; Collet, A.; Blanchet, G. Involvement of the different rat hippocampal glutamatergic receptors in development of seizures induced by soman: An autoradiographic study. Neurotoxicology 1991, 12, 655-664. [Pub Med]
45. Lallement, G.; Carpentier, P.; Collet, A.; Pernot-Marino, I.; Baubichon, D.; Blanchet, G. Effects of soman-induced seizures on different extracellular amino acid levels and on glutamate uptake in rat hippocampus. Brain Res. 1991, 563, 234-240. [Cross Ref]
46. Wade, J.V.; Samson, F.E.; Nelson, S.R.; Pazdernik, T.L. Changes in extracellular amino acids during soman- and kainic acid-induced seizures. J. Neurochem. 1987, 49, 645-650. [Cross Ref] [Pub Med]
47. Grasshoff, C.; Gillessen, T.; Thiermann, H.; Wagner, E.; Szinicz, L. The effect of acetylcholinesterase inhibition on depolarization-induced GABA release from rat striatal slices. Toxicology 2003, 1184, 149-156. [Cross Ref]
48. Santos, M.D.; Pereira, E.F.; Aracava, Y.; Castro, N.G.; Fawcett, W.P.; Randall, W.R.; Albuquerque, E.X. Low concentrations of pyridostigmine prevent soman-induced inhibition of GABAergic transmission in the central nervous system: Involvement of muscarinic receptors. J. Pharmacol. Exp. Ther. 2003, 304, 254-265. [Cross Ref] [Pub Med]
49. Solberg, Y.; Belkin, M. The role of excitotoxicity in organophosphorous nerve agents central poisoning. Trends Pharmacol. Sci. 1997, 18, 183-185. [Cross Ref]
50. Carpentier, P.; Lambrinidis, M.; Blanchet, G. Early dendritic changes in hippocampal pyramidal neurones (field CA1) of rats subjected to acute soman intoxication: A light microscopic study. Brain Res. 1991, 541, 293-299. [Cross Ref]
51. McDonough, H.J., Jr.; Shih, T.-M. Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology. Neurosci. Biobehav. Rev. 1997, 21, 559-579. [Cross Ref]
52. Wood, S.J.; Tattersall, J.E. An improved brain slice model of nerve agent-induced seizure activity. J. Appl. Toxicol. 2001, 21 (Suppl. 1), S83-S86. [Cross Ref] [Pub Med]
53. Okumura, T.; Hisaoka, T.; Naito, T.; Isonuma, H.; Okumura, S.; Miura, K.; Maekawa, H.; Ishimatsu, S.; Takasu, N.; Suzuki, K. Acute and chronic effects of sarin exposure from the Tokyo subway incident. Environ. Toxicol. Pharmacol. 2005, 19, 447-450. [Cross Ref] [Pub Med]
54. Yokoyama, K.; Araki, S.; Murata, K.; Nishikitani, M.; Okumura, T.; Ishimatsu, S.; Takasu, N.; White, R.F. Chronic neurobehavioral effects of Tokyo subway sarin poisoning in relation to posttraumatic stress disorder. Arch. Environ. Health 1998, 53, 249-256. [Cross Ref] [Pub Med]
55. Yamasue, H.; Abe, O.; Kasai, K.; Suga, M.; Iwanami, A.; Yamada, H.; Tochigi, M.; Ohtani, T.; Rogers, M.A.; Sasaki, T.; et al. Human brain structural change related to acute single exposure to sarin. Ann. Neurol. 2007, 61, 37-46. [Cross Ref] [Pub Med]
56. Horn, J.; Haley, R.; Kurt, T. Neuropsychological correlates of Gulf War syndrome. Arch. Clin. Neuropsychol. 1997, 12, 531-544.
57. Proctor, S.P.; Heaton, K.J.; Heeren, T.; White, R.F. Effects of sarin and cyclosarin exposure during the 1991 Gulf War on neurobehavioral functioning in US army veterans. Neurotoxicology 2006, 27, 931-939. [Cross Ref] [Pub Med]
58. Hoffman, A.; Eisenkraft, A.; Finkelstein, A.; Schein, O.; Rotman, E.; Dushnitsky, T. A decade after the Tokyo sarin attack: A review of neurological follow-up of the victims. Mil. Med. 2007, 172, 607-610. [Cross Ref] [Pub Med]
59. Ohtani, T.; Iwanami, A.; Kasai, K.; Yamasue, H.; Kato, T.; Sasaki, T.; Kato, N. Post-traumatic stress disorder symptoms in victims of Tokyo subway attack: A 5-year follow-up study. Psychiatry Clin. Neurosci. 2004, 58, 624-629. [Cross Ref] [Pub Med]
60. Miyaki, K.; Nishiwaki, Y.; Maekawa, K.; Ogawa, Y.; Asukai, N.; Yoshimura, K.; Etoh, N.; Matsumoto, Y.; Kikuchi, Y.; Kumagai, N.; et al. Effects of sarin on the nervous system of subway workers seven years after the Tokyo subway sarin attack. J. Occup. Health 2005, 47, 299-304. [Cross Ref] [Pub Med]
61. Beard, J.D.; Umbach, D.M.; Hoppin, J.A.; Richards, M.; Alavanja, M.C.; Blair, A.; Sandler, D.P.; Kamel, F. Pesticide exposure and depression among male private pesticide applicators in the agricultural health study. Environ. Health Perspect. 2014, 122, 984-991. [Cross Ref] [Pub Med]
62. Bowler, R.M.; Mergler, D.; Huel, G.; Cone, J.E. Psychological, psychosocial, psychophysiological sequelae in a community affected by a railroad chemical disaster. J. Trauma. Stress 1994, 7, 601-624. [Cross Ref] [Pub Med]
63. Di Giovanni, C., Jr. Domestic terrorism with chemical or biological agents: Psychiatric aspects. Am. J. Psychiatry 1999, 156, 1500-1505. [Cross Ref] [Pub Med]
64. Ross, S.J.M.; Brewin, C.R.; Curran, H.V.; Furlong, C.E.; Abraham-Smith, K.M.; Harrison, V. Neuropsychological and psychiatric functioning in sheep farmers exposed to low levels of organophosphate pesticides. Neurotoxicol. Teratol. 2010, 12, 452-459. [Cross Ref] [Pub Med]
65. Toomey, R.; Alpern, R.; Vasterling, J.J.; Baker, D.G.; Reda, D.J.; Lyons, M.J.; Henderson, W.G.; Kang, H.K.; Eisen, S.A.; Murphy, F.M. Neuropsychological functioning of U.S. Gulf War veterans 10 years after the war. J. Int. Neuropsychol. Soc. 2009, 15, 717-729. [Cross Ref] [Pub Med]
66. Bowers, M.B.; Goodman, E.; Sim, V.M. Some behavioral changes in man following anti-cholinesterase administration. J. Nerv. Ment. Dis. 1964, 138, 383-389. [Pub Med]
67. Chao, L.L.; Rothlind, J.C.; Cardenas, V.A.; Meyerhoff, J.D.; Weiner, M.W. Effects of low-level exposure to sarin and cycloarin during the 1991 Gulf War on brain function and brain structure in US veterans. Neurotoxicology 2010, 31, 493-501. [Cross Ref] [Pub Med]
68. Chao, L.L.; Abadjian, L.; Hlavin, J.; Meyerhoff, D.J.; Weiner, M.W. Effects of low-level sarin and cyclosarin exposure and Gulf War Illness on brain structure and function: A study at 4T. Neurotoxicology 2011, 32, 814-822. [Cross Ref] [Pub Med]
69. Brandeis, R.; Raveh, L.; Grunwald, J.; Cohen, E.; Ashani, Y. Prevention of soman-induced cognitive deficits by pretreatment with human butyrylcholinesterase in rats. Pharmacol. Biochem. Behav. 1993, 46, 889-896. [Cross Ref]
70. Filliat, P.; Baubichon, D.; Burckhart, M.F.; Pernot-Marino, I.; Foquin, A.; Masqueliez, C.; Perrichon, C.; Carpentier, P.; Lallement, G. Memory impairment after soman intoxication in rat: Correlation with central neuropathology. Improvement with anticholinergic and antiglutamatergic therapeutics. Neurotoxicology 1999, 20, 535-549. [Pub Med]
71. Filliat, P.; Coubard, S.; Pierard, C.; Liscia, P.; Beracochea, D.; Four, E.; Baubichon, D.; Masqueliez, C.; Lallement, G.; Collombet, J.M. Long-term behavioral consequences of soman poisoning in mice. Neurotoxicology 2007, 28, 508-519. [Cross Ref] [Pub Med]
72. Finkelstein, A.; Kunis, G.; Berkutzki, T.; Ronen, A.; Krivoy, A.; Yoles, E.; Last, D.; Mardor, Y.; van Shura, K.; McFarland, E.; et al. Immunomodulation by poly-YE reduces organophosphate-induced brain damage. Brain Behav. Immun. 2012, 26, 159-169. [Cross Ref] [Pub Med]
73. Joosen, M.J.; Jousma, E.; van den Boom, T.M.; Kuijpers, W.C.; Smit, A.B.; Lucassen, P.J.; van Helden, H.P. Long-term cognitive deficits accompanied by reduced neurogenesis after soman poisoning. Neurotoxicology 2009, 30, 72-80. [Cross Ref] [Pub Med]
74. Buccafusco, J.J.; Heithold, D.L.; Chon, S.H. Long-term behavioral and learning abnormalities produced by the irreversible cholinesterase inhibitor soman: Effect of a standard pretreatment regimen and clonidine. Toxicol. Lett. 1990, 52, 319-329. [Cross Ref]
75. Choi, E.K.; Park, D.; Yon, J.M.; Hur, G.H.; Ha, Y.C.; Che, J.H.; Kim, J.; Shin, S.; Jang, J.Y.; Hwang, S.Y.; et al. Protection by sustained release of physostigmine and procyclidine of soman poisoning in rats. Eur. J. Pharmacol. 2004, 505, 83-91. [Cross Ref] [Pub Med]
76. Pan, H.; Piermartiri, T.C.; Chen, J.; McDonough, J.; Oppel, C.; Driwech, W.; Winter, K.; McFarland, E.; Black, K.; Figueiredo, T.; et al. Repeated administration of α-linolenic acid exerts neuroprotective efficacy, an anti-depressant effect and improves cognitive performance when given after soman exposure. Neurotoxicology 2015, 51, 38-50. [Cross Ref] [Pub Med]
77. Moffett, M.C.; Schultz, M.K.; Schwartz, J.E.; Stone, M.F.; Lumley, L.A. Impaired auditory and contextual fear conditioning in soman-exposed rats. Pharmacol. Biochem. Behav. 2011, 98, 120-129. [Cross Ref] [Pub Med]
78. Coubard, S.; Béracochéa, D.; Collombet, J.M.; Philippin, J.N.; Krazem, A.; Liscia, P.; Lallement, G.; Piérard, C. Long-term consequences of soman poisoning in mice: Part 2. Emotional behavior. Behav. Brain Res. 2008, 191, 95-103. [Cross Ref] [Pub Med]
79. Langston, J.L.; Wright, L.K.; Connis, N.; Lumley, L.A. Characterizing the behavioral effects of nerve agent-induced seizure activity in rats: Increased startle reactivity and perseverative behavior. Pharmacol. Biochem. Behav. 2012, 100, 382-391. [Cross Ref] [Pub Med]
80. Prager, E.M.; Aroniadou-Anderjaska, V.; Almeida-Suhett, C.P.; Figueiredo, T.H.; Apland, J.P.; Rossetti, F.; Olsen, C.H.; Braga, M.F. The recovery of acetylcholinesterase activity and the progression of neuropathological and pathophysiological alterations in the rat basolateral amygdala after soman-induced status epilepticus: Relation to anxiety-like behavior. Neuropharmacology 2014, 81, 64-74. [Cross Ref] [Pub Med]
81. Lallement, G.; Denoyer, M.; Collet, A.; Pernot-Marino, I.; Baubichon, D.; Monmaur, P.; Blanchet, G. Changes in hippocampal acetylcholine and glutamate extracellular levels during soman-induced seizures; influence of septal cholinoceptive cells. Neurosci. Lett. 1992, 139, 104-107. [Cross Ref]
82. McDonough, J.H.; McMonagle, J.; Copeland, T.; Zoeffel, D.; Shih, T.-M. Comparative evaluation of benzodiazepines for control of soman-induced seizures. Arch. Toxicol. 1999, 73, 473-478. [Cross Ref] [Pub Med]
83. McDonough, J.H.; Dochterman, L.W.; Smith, C.D.; Shih, T.-M. Protection against nerve agent-induced neuropathology, but not cardiac pathology, is associated with the anticonvulsant action of drug treatment. Neurotoxicology 1995, 15, 123-132.
84. McDonough, J.H.; Zoeffel, L.D.; McMonagle, J.; Copeland, T.L.; Smith, C.D.; Shih, T.-M. Anticonvulsant treatment of nerve agent seizures anticholinergics versus diazepam in soman-intoxicated Guinea pigs. Epilepsy Res. 2000, 38, 1-14. [Cross Ref]
85. Clement, J.G.; Broxup, B. Efficacy of diazepam and avizafone against soman-induced neuropathology in brain of rats. Neurotoxicology 1993, 14, 485-504. [Pub Med]
86. Apland, J.P.; Aroniadou-Anderjaska, V.; Figueiredo, T.H.; Rossetti, F.; Miller, S.L.; Braga, M.F. The limitations of diazepam as a treatment for nerve agent-induced seizures and neuropathology in rats: Comparison with UBP302. J. Pharmacol. Exp. Ther. 2014, 351, 359-372. [Cross Ref] [Pub Med]
87. Rossetti, F.; de Araujo Furtado, M.; Pak, T.; Bailey, K.; Shields, M.; Chanda, S.; Addis, M.; Robertson, B.D.; Moffett, M.; Lumley, L.A.; et al. Combined diazepam and HDAC inhibitor treatment protects against seizures and neuronal damage caused by soman exposure. Neurotoxicology 2012, 33, 500-511. [Cross Ref] [Pub Med]
88. Singer, A.W.; Jaax, N.K.; Graham, J.S.; McLeod, C.G., Jr. Cardiomyopathy in soman and sarin intoxicated rats. Toxicol. Lett. 1987, 36, 243-249. [Cross Ref]
89. De Araujo Furtado, M.; Lumley, L.A.; Robison, C.; Tong, L.C.; Lichtenstein, S.; Yourick, D.L. Spontaneous recurrent seizures after status epilepticus induced by soman in Sprague-Dawley rats. Epilepsia 2010, 51, 1503-1510. [Cross Ref] [Pub Med]
90. Apland, J.P.; Aroniadou-Anderjaska, V.; Braga, M.F. Soman induces ictogenesis in the amygdala and interictal activity in the hippocampus that are blocked by a GluR5 kainate receptor antagonist in vitro. Neuroscience 2009, 159, 380-389. [Cross Ref] [Pub Med]
91. Baille, V.; Clarke, P.G.; Brochier, G.; Dorandeu, F.; Verna, J.M.; Four, E.; Lallement, G.; Carpentier, P. Soman-induced convulsions: The neuropathology revisited. Toxicology 2005, 215, 1-24. [Cross Ref] [Pub Med]
92. Fujikawa, D.G.; Shinmei, S.S.; Cai, B. Seizure-induced neuronal necrosis: Implications for programmed cell death mechanisms. Epilepsia 2000, 41 (Suppl. 6), S9-S13. [Cross Ref] [Pub Med]
93. Lallement, G.; Delamanche, I.S.; Pernot-Marino, I.; Baubichon, D.; Denoyer, M.; Carpentier, P.; Blanchet, G. Neuroprotective activity of glutamate receptor antagonists against soman-induced hippocampal damage: Quantification with an omega 3 site ligand. Brain Res. 1993, 618, 227-237. [Cross Ref]
94. Raveh, L.; Chapman, S.; Cohen, G.; Alkalay, D.; Gilat, E.; Rabinovitz, I.; Weissman, B.A. The involvement of the NMDA receptor complex in the protective effect of anticholinergic drugs against soman poisoning. Neurotoxicology 1999, 20, 551-559. [Pub Med]
95. Dematteis, M.; Mallaret, M.; Baubichon, D.; Pernot-Marino, I.; Lallement, G. Evaluation of dextromethorphan and dextrorphan as a preventive treatment of soman toxicity in mice. Neurosci. Lett. 1997, 234, 91-94. [Cross Ref]
96. White, H.S.; Alex, A.B.; Pollock, A.; Hen, N.; Shekh-Ahmad, T.;Wilcox, K.S.; McDonough, J.H.; Stables, J.P.; Kaufmann, D.; Yagen, B.; et al. A new derivative of valproic acid amide possesses a broad-spectrum antiseizure profile and unique activity against status epilepticus and organophosphate neuronal damage. Epilepsia 2012, 53, 134-146. [Cross Ref] [Pub Med]
97. Shekh-Ahmad, T.; Hen, N.; McDonough, J.H.; Yagen, B.; Bialer, M. Valnoctamide and sec-butyl-propylacetamide (SPD) for acute seizures and status epilepticus. Epilepsia 2013, 54 (Suppl. 6), 99-102. [Cross Ref] [Pub Med]
98. Gunosewoyo, H.; Tipparaju, S.K.; Pieroni, M.; Wang, Y.; Doctor, B.P.; Nambiar, M.P.; Kozikowski, A.P. Structural analogs of huperzine A improve survival in Guinea pigs exposed to soman. Bioorg. Med. Chem. Lett. 2013, 23, 1544-1547. [Cross Ref] [Pub Med]
99. Myhrer, T.; Enger, S.; Mariussen, E.; Aas, P. Two medical therapies very effective shortly after high levels of soman poisoning in rats, but only one with universal utility. Toxicology 2013, 314, 221-228. [Cross Ref]
100. Schmued, L.C.; Stowers, C.C.; Scallet, A.C.; Xu, L. Fluoro-Jade C results in ultra high resolution and contrast labeling of degenerating neurons. Brain Res. 2005, 1035, 24-31. [Cross Ref] [Pub Med]
101. He, Z.; Crook, J.E.; Meschia, J.F.; Brott, T.G.; Dickson, D.W.; McKinney, M. Aging blunts ischemic-preconditioning-induced neuroprotection following transient global ischemia in rats. Curr. Neurovasc. Res. 2005, 2, 365-374. [Cross Ref] [Pub Med]
102. Bowyer, J.F.; Schmued, L.C. Fluoro-Ruby labeling prior to an amphetamine neurotoxic insult shows a definitive massive loss of dopaminergic terminals and axons in the caudate-putamen. Brain Res. 2006, 1075, 236-239. [Cross Ref] [Pub Med]
103. Bowyer, J.F.; Ali, S. High doses of methamphetamine that cause disruption of the blood-brain barrier in limbic regions produce extensive neuronal degeneration in mouse hippocampus. Synapse 2006, 60, 521-532. [Cross Ref] [Pub Med]
104. Lee, S.T.; Chu, K.; Park, J.E.; Kang, L.; Ko, S.Y.; Jung, K.H.; Kim, M. Memantine reduces striatal cell death with decreasing calpain level in 3-nitropropionic model of Huntington's disease. Brain Res. 2006, 1118, 199-207. [Cross Ref] [Pub Med]
105. Figueiredo, T.H.; Aroniadou-Anderjaska, V.; Qashu, F.; Apland, J.P.; Pidoplichko, V.; Stevens, D.; Ferrara, T.M.; Braga, M.F. Neuroprotective efficacy of caramiphen against soman and mechanisms of its action. Br. J. Pharmacol. 2011, 164, 1495-1505. [Cross Ref] [Pub Med]
106. Gu, Q.; Schmued, L.C.; Sarkar, S.; Paule, M.G.; Raymick, B. One-step labeling of degenerative neurons in unfixed brain tissue samples using Fluoro-Jade C. J. Neurosci. Methods 2012, 208, 40-43. [Cross Ref] [Pub Med]
107. Haley, R.; Kurt, T. Self-reported exposure to neurotoxic chemical combinations in the Gulf War: A cross-sectional epidemiologic study. JAMA 1997, 277, 231-237. [Cross Ref] [Pub Med]
108. Nishiwaki, Y.; Maekawa, K.; Ogawa, Y.; Asukai, N.; Minami, M.; Omae, K.; Sarin Health Effects Study Group. Effects of sarin on the nervous system in rescue team staff members and police officers 3 years after the Tokyo subway sarin attack. Environ. Health Perspect. 2001, 109, 1169-1173. [Cross Ref] [Pub Med]
109. Baze, W.B. Soman-induced morphological changes: An overview in the non-human primate. J. Appl. Toxicol. 1993, 13, 173-177. [Cross Ref] [Pub Med]
110. Carpentier, P.; Delamanche, I.S.; le Bert, M.; Blanchet, G.; Bouchaud, C. Seizure-related opening of the blood-brain barrier induced by soman: Possible correlation with the acute neuropathology observed in poisoned rats. Neurotoxicology 1990, 11, 493-508. [Pub Med]
111. Prager, E.M.; Aroniadou-Anderjaska, V.; Almeida-Suhett, C.P.; Figueiredo, T.H.; Apland, J.P.; Braga, M.F. Acetylcholinesterase inhibition in the basolateral amygdala plays a key role in the induction of status epilepticus after soman exposure. Neurotoxicology 2013, 38, 84-90. [Cross Ref] [Pub Med]
112. Myers, T.M.; Langston, J.L. Diet composition exacerbates or attenuates soman toxicity in rats: Implied metabolic control of nerve agent toxicity. Neurotoxicology 2011, 32, 342-349. [Cross Ref] [Pub Med]
113. Philippens, I.H.; Melchers, B.P.; de Groot, D.M.; Wolthuis, O.L. Behavioral performance, brain histology, and EEG sequela after immediate combined atropine/diazepam treatment of soman-intoxicated rats. Pharmacol. Biochem. Behav. 1992, 42, 711-719. [Cross Ref]
114. Pernot, F.; Carpentier, P.; Baille, V.; Testylier, G.; Beaup, C.; Foquin, A.; Filliat, P.; Liscia, P.; Coutan, M.; Piérard, C.; et al. Intrahippocampal cholinesterase inhibition induces epileptogenesis in mice without evidence of neurodegenerative events. Neuroscience 2009, 162, 1351-1365. [Cross Ref] [Pub Med]
115. Rodriguiz, R.M.; Wetsel, W.C. Assessments of cognitive deficits in mutuant mice. In Animal Models of Cognitive Impairment; Levin, E.D., Buccafusco, J.J., Eds.; CRC Press: Boca Raton, FL, USA, 2006.
116. Cryan, J.F.; Markou, A.; Lucki, I. Assessing antidepressant activity in rodents: Recent developments and future needs. Trends Pharmacol. Sci. 2002, 23, 238-245. [Cross Ref]
117. Porsolt, R.D.; Bertin, A.; Jalfre, M. Behavioral despair in mice: A primary screening test for antidepressants. Arch. Int. Pharmacodyn. Ther. 1977, 229, 327-336. [Pub Med]
118. Toomey, R.; Kang, H.K.; Karlinsky, J.; Baker, D.G.; Vasterling, J.J.; Alpern, R.; Reda, D.J.; Henderson, W.G.; Murphy, F.M.; Eisen, S.A. Mental health of US Gulf War veterans 10 years after the war. Br. J. Psychiatry 2007, 190, 385-393. [Cross Ref] [Pub Med]
119. Bazylewicz-Walczak, B.; Majczakowa, W.; Szymczak, M. Behavioral effects of occupational exposure to organophosphorous pesticides in female greenhouse planting workers. Neurotoxicology 1999, 20, 819-826. [Pub Med]
120. Campbell, S.; MacQueen, G. An update on regional brain volume differences associated with mood disorders. Curr. Opin. Psychiatry 2006, 19, 25-33. [Cross Ref] [Pub Med]
121. Cotter, D.; Mackay, D.; Landau, S.; Kerwin, R.; Everall, I. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch. Gen. Psychiatry 2001, 58, 543-553. [Cross Ref]
122. Tizabi, Y.; Hauser, S.R.; Tyler, K.Y.; Getachew, B.; Madani, R.; Sharma, Y.; Manaye, K.F. Effects of nicotine on depressive-like behavior and hippocampal volume of female WKY rats. Prog. Neuropsycholopharmacol. Biol. Psychiatry 2010, 34, 62-69. [Cross Ref] [Pub Med]
123. Heaton, K.J.; Palumbo, C.L.; Proctor, S.P.; Killiany, R.J.; Yurgelun-Todd, D.A.; White, R.F. Quantitative magnetic resonance brain imaging in US army veterans of the 1991 Gulf War potentially exposed to sarin and cyclosarin. Neurotoxicology 2007, 28, 761-769. [Cross Ref] [Pub Med]
124. Chao, L.L.; Kriger, S.; Buckley, S.; Ng, P.; Mueller, S.G. Effects of low-level sarin and cyclosarin exposure on hippocampal subfields in Gulf War Veterans. Neurotoxicology 2014, 44, 263-269. [Cross Ref] [Pub Med]
125. Sapolsky, R.M. Is impaired neurogenesis relevant to the affective symptoms of depression? Biol. Psychiatry 2004, 56, 137-139. [Cross Ref] [Pub Med]
126. Miyazawa, D.; Yasui, Y.; Yamada, K.; Ohara, N.; Okuyama, H. Biochemical responses to dietary α-linolenic acid restriction proceed differently among brain regions in mice. Biomed. Res. 2011, 32, 237-245. [Cross Ref] [Pub Med]
127. Lucas, M.; Mirzaei, F.; O'Reilly, E.J.; Pan, A.; Willett, W.C.; Kawachi, I.; Koenen, K.; Ascherio, A. Dietary intake of n-3 and n-6 fatty acids and the risk of clinical depression in women: A 10-years prospective follow-up study. Am. J. Clin. Nutr. 2011, 93, 1337-1343. [Cross Ref] [Pub Med]
128. Hibbeln, J.R. Fish consumption and major depression. Lancet 1998, 351, 1213. [Cross Ref]
129. Peet, M.; Murphy, B.; Shay, J.; Horrobin, D. Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol. Psychiatry 1998, 43, 315-319. [Cross Ref]
130. Peet, M.; Stokes, C. Omega-3 fatty acids in the treatment of psychiatric disorders. Drugs 2005, 65, 1041-1059. [Cross Ref]
131. Venna, V.R.; Deplanque, D.; Allet, C.; Belarbi, K.; Hamdane, M.; Bordet, R. PUFA induce antidepressant-like effects in parallel to structural and molecular changes in the hippocampus. Psychoneuroendocrinology 2009, 34, 199-211. [Cross Ref] [Pub Med]
132. Haghighi, F.; Galfalvy, H.; Chen, S.; Huang, Y.Y.; Cooper, T.B.; Burke, A.K.; Oquendo, M.A.; Mann, J.J.; Sublette, M.E. DNA methylation perturbations in genes involved in polyunsaturated Fatty Acid biosynthesis associated with depression and suicide risk. Front Neurol. 2015, 6, 92. [Cross Ref] [Pub Med]
133. Conner, J.M.; Lauterborn, J.C.; Yan, Q.; Gall, C.M.; Varon, S. Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: Evidence for anterograde axonal transport. J. Neurosci. 1997, 17, 2295-2313. [Pub Med]
134. Aloyz, R.; Fawcett, J.P.; Kaplan, D.R.; Murphy, R.A.; Miller, F.D. Activity-dependent activation of TrkB neurotrophin receptors in the adult CNS. Learn Mem 1999, 6, 216-231. [Pub Med]
135. Thoenen, H. Neurotrophins and neuronal plasticity. Science 1995, 270, 593-598. [Cross Ref] [Pub Med]
136. Katoh-Semba, R.; Asano, T.; Ueda, H.; Morishita, R.; Takeuchi, I.K.; Inaguma, Y.; Kato, K. Riluzole enhances expression of brain-derived neurotrophic factor with consequent proliferation of granule precursor cells in the rat hippocampus. FASEB J. 2002, 16, 1328-1330. [Cross Ref] [Pub Med]
137. Lee, J.; Duan, W.; Mattson, M.P. Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice. J. Neurochem. 2002, 82, 1367-1375. [Cross Ref] [Pub Med]
138. Shirayama, Y.; Chen, A.C.; Nakagawa, S.; Russell, D.S.; Duman, R.S. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J. Neurosci. 2002, 22, 3251-3261. [Pub Med]
139. Deltheil, T.; Guiard, B.P.; Cerdan, J.; David, D.J.; Tanaka, K.F.; Repérant, C.; Guilloux, J.P.; Coudoré, F.; Hen, R.; Gardier, A.M. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice. Neuropharmacology 2008, 55, 1006-1014. [Cross Ref] [Pub Med]
140. Castrén, E.; Võikar, V.; Rantamäki, T. Role of neurotrophic factors in depression. Curr. Opin. Pharmacol. 2007, 7, 18-21. [Cross Ref] [Pub Med]
141. Lindholm, J.S.; Castrén, E. Mice with altered BDNF signaling as models for mood disorders and antidepressant effects. Front. Behav. Neurosci. 2014, 8, 1-10. [Cross Ref] [Pub Med]
142. Schmidt, H.D.; Duman, R.S. Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models. Neuropsychopharmacology 2010, 35, 2378-2391. [Cross Ref] [Pub Med]
143. Adachi, M.; Barrot, M.; Autry, A.E.; Theobald, D.; Monteggia, L.M. Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy. Biol. Psychiatry 2008, 63, 642-649. [Cross Ref] [Pub Med]
144. Li, Y.; Luikart, B.W.; Birnbaum, S.; Chen, J.; Kwon, C.H.; Kernie, S.G.; Bassel-Duby, R.; Parada, L.F. TrkB regulates hippocampal neurogenesis and governs sensitivity to antidepressive treatment. Neuron 2008, 59, 399-412. [Cross Ref] [Pub Med]
145. Saarelainen, T.; Hendolin, P.; Lucas, G.; Koponen, E.; Sairanen, M.; MacDonald, E.; Agerman, K.; Haapasalo, A.; Nawa, H.; Aloyz, R.; et al. Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J. Neurosci. 2003, 23, 349-357. [Pub Med]
146. Phelps, E.A. Human emotion and memory: Interactions of the amygdala and hippocampal complex. Curr. Opin. Neurobiol. 2004, 14, 198-202. [Cross Ref] [Pub Med]
147. Isaacson, R.L.; Wickelgren, W.O. Hippocampal ablation and passive avoidance. Science 1962, 138, 1104-1106. [Cross Ref] [Pub Med]
148. Hirsh, R. The hippocampus and contextual retrieval of information from memory: A theory. Behav. Biol. 1974, 12, 421-444. [Cross Ref]
149. Riekkinen, P., Jr.; Riekkinen, M.; Sirviö, J. Cholinergic drugs regulate passive avoidance performance via the amygdala. J. Pharmacol. Exp. Ther. 1993, 267, 1484-1492. [Pub Med]
150. Ghiasvand, M.; Rezayof, A.; Zarrindast, M.R.; Ahmadi, S. Activation of cannabinoid CB1 receptors in the central amygdala impairs inhibitory avoidance memory consolidation via NMDA receptors. Neurobiol. Learn. Mem. 2011, 96, 333-338. [Cross Ref] [Pub Med]
151. Tóth, K.; László, K.; Lukács, E.; Lénárd, L. Intraamygdaloid microinjection of acylated-ghrelin influences passive avoidance learning. Behav. Brain Res. 2009, 202, 308-311. [Cross Ref] [Pub Med]
152. László, K.; Tóth, K.; Kertes, E.; Péczely, L.; Ollmann, T.; Madarassy-Szücs, A.; Lénárd, L. The role of neurotensin in passive avoidance learning in the rat central nucleus of amygdala. Behav. Brain Res. 2012, 226, 597-600. [Cross Ref] [Pub Med]
153. Walsh, T.J.; Tilson, H.A.; De Haven, D.L.; Mailman, R.B.; Fisher, A.; Hanin, I. AF64A, a cholinergic neurotoxin, selectively depletes acetylcholine in hippocampus and cortex, and produces long-term passive avoidance and radial-arm maze deficits in the rat. Brain Res. 1984, 21, 91-102. [Cross Ref]
154. Dobryakova, Y.V.; Gurskaya, O.Y.; Markevich, V.A. Administration of nicotinic receptor antagonists during the period of memory consolidation affects passive avoidance learning and modulates synaptic efficiency in the CA1 region in vivo. Neuroscience 2015, 284, 865-871. [Cross Ref] [Pub Med]
155. Maia, G.H.; Quesado, J.L.; Soares, J.I.; do Carmo, J.M.; Andrade, P.A.; Andrade, J.P.; Lukoyanov, N.V. Loss of hippocampal neurons after kainate treatment correlates with behavioral deficits. PLoS ONE 2014, 9, e84722. [Cross Ref] [Pub Med]
156. Collombet, J.M.; Piérard, C.; Béracochéa, D.; Coubard, S.; Burckhart, M.F.; Four, E.; Masqueliez, C.; Baubichon, D.; Lallement, G. Long-term consequences of soman poisoning in mice Part 1. Neuropathology and neuronal regeneration in the amygdala. Behav. Brain Res. 2008, 191, 88-94. [Cross Ref] [Pub Med]
157. Collombet, J.M.; Carpentier, P.; Baille, V.; Four, E.; Bernabe, D.; Burckhart, M.-F.; Masqueliez, C.; Baubichon, D.; Lallement, G. Neuronal regeneration partially compensates the delayed neuronal cell death observed in the hippocampal CA1 field of soman-poisoned mice. Neurotoxicology 2006, 27, 201-209. [Cross Ref] [Pub Med]
158. Collombet, J.M.; Four, E.; Bernabé, D.; Masqueliez, C.; Burckhart, M.F.; Baille, V.; Baubichon, D.; Lallement, G. Soman poisoning increases neural progenitor proliferation and induces long-term glial activation in mouse brain. Toxicology 2005, 208, 319-334. [Cross Ref] [Pub Med]
159. Saxe, M.D.; Battaglia, F.;Wang, J.W.; Malleret, G.; David, D.J.; Monckton, J.E.; Garcia, A.D.; Sofroniew, M.V.; Kandel, E.R.; Santarelli, L.; et al. Ablation of hippocampal neurogenesis impairs contextual fear conditioning and synaptic plasticity in the dentate gyrus. Proc. Natl. Acad. Sci. USA 2006, 103, 17501-17506. [Cross Ref] [Pub Med]
160. Gheusi, G.; Cremer, H.; McLean, H.; Chazal, G.; Vincent, J.D.; Lledo, P.M. Importance of newly generated neurons in the adult olfactory bulb for odor discrimination. Proc. Natl. Acad. Sci. USA 2000, 97, 1823-1828. [Cross Ref] [Pub Med]
161. Cameron, H.A.; McKay, R.D. Adult neurogenesis produces a large pool of new granule cells in the dentate gyrus. J. Comp. Neurol. 2001, 435, 406-417. [Cross Ref] [Pub Med]
162. Gage, F.H.; Kempermann, G.; Palmer, T.D.; Peterson, D.A.; Ray, J. Multipotent progenitor cells in the adult dentate gyrus. J. Neurobiol. 1998, 36, 249-266. [Cross Ref]
163. Gage, F.H. Mammalian neural stem cells. Science 2000, 287, 1433-1438. [Cross Ref] [Pub Med]
164. Van Praag, H.; Schinder, A.F.; Christie, B.R.; Toni, N.; Palmer, T.D.; Gage, F.H. Functional neurogenesis in the adult hippocampus. Nature 2002, 415, 1030-1034. [Cross Ref] [Pub Med]
165. Merz, K.; Herold, S.; Lie, D.C. CREB in adult neurogenesis-Master and partner in the development of adult-born neurons? Eur. J. Neurosci. 2011, 33, 1078-1086. [Cross Ref] [Pub Med]
166. Sairanen, M.; Lucas, G.; Ernfors, P.; Castrén, M.; Castrén, E. Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus. J. Neurosci. 2005, 25, 1089-1094. [Cross Ref] [Pub Med]
167. Platel, J.C.; Stamboulian, S.; Nguyen, I.; Bordey, A. Neurotransmitter signaling in postnatal neurogenesis: The first leg. Brain Res. Rev. 2010, 63, 60-71. [Cross Ref] [Pub Med]
168. Kempermann, G.; Kuhn, H.G.; Gage, F.H. More hippocampal neurons in adult mice living in an enriched environment. Nature 1997, 386, 493-495. [Cross Ref] [Pub Med]
169. Leuner, B.; Gould, E.; Shors, T.J. Is there a link between adult neurogenesis and learning? Hippocampus 2006, 16, 216-224. [Cross Ref] [Pub Med]
170. Imayoshi, I.; Sakamoto, M.; Ohtsuka, T.; Takao, K.; Miyakawa, T.; Yamaguchi, M.; Mori, K.; Ikeda, T.; Itohara, S.; Kageyama, R. Roles of continuous neurogenesis in the structural and functional integrity of the adult forebrain. Nat. Neurosci. 2008, 11, 1153-1161. [Cross Ref] [Pub Med]
171. Warner-Schmidt, J.L.; Madsen, T.M.; Duman, R.S. Electroconvulsive seizure restores neurogenesis and hippocampus-dependent fear memory after disruption by irradiation. Eur. J. Neurosci. 2008, 27, 1485-1493. [Cross Ref] [Pub Med]
172. Winocur, G.; Wojtowicz, J.M.; Sekeres, M.; Snyder, J.S.; Wang, S. Inhibition of neurogenesis interferes with hippocampus-dependent memory function. Hippocampus 2006, 16, 296-304. [Cross Ref] [Pub Med]
173. Denny, C.A.; Burghardt, N.S.; Schachter, D.M.; Hen, R.; Drew, M.R. 4- to 6-week-old adult-born hippocampal neurons influence novelty-evoked exploration and contextual fear conditioning. Hippocampus 2012, 22, 1188-1201. [Cross Ref] [Pub Med]
174. Snyder, J.S.; Hong, N.S.; McDonald, R.J.;Wojtowicz, J.M. A role for adult neurogenesis in spatial long-term memory. Neuroscience 2005, 130, 843-852. [Cross Ref] [Pub Med]
175. Shors, T.J.; Miesegaes, G.; Beylin, A.; Zhao, M.; Rydel, T.; Gould, E. Neurogenesis in the adult is involved in the formation of trace memories. Nature 2001, 410, 372-376. [Cross Ref] [Pub Med]
176. Clelland, C.D.; Choi, M.; Romberg, C.; Clemenson, G.D., Jr.; Fragniere, A.; Tyers, P.; Jessberger, S.; Saksida, L.M.; Barker, R.A.; Gage, F.H.; et al. A functional role for adult hippocampal neurogenesis in spatial pattern separation. Science 2009, 325, 210-213. [Cross Ref] [Pub Med]
177. Petrik, D.; Lagace, D.C.; Eisch, A.J. The neurogenesis hypothesis of affective and anxiety disorders: Are we mistaking the scaffolding for the building? Neuropharmacology 2012, 62, 21-34. [Cross Ref] [Pub Med]
178. Oh, S.B.; Park, H.R.; Jang, Y.J.; Choi, S.Y.; Son, T.G.; Lee, J. Baicalein attenuates impaired hippocampal neurogenesis and the neurocognitive deficits induced by gamma-ray radiation. Br. J. Pharmacol. 2013, 168, 421-431. [Cross Ref] [Pub Med]
179. Suarez-Pereira, I.; Canals, S.; Carrion, A.M. Adult newborn neurons are involved in learning acquisition and long-term memory formation: The distinct demands on temporal neurogenesis of different cognitive tasks. Hippocampus 2015, 25, 51-61. [Cross Ref] [Pub Med]
180. Santarelli, L.; Saxe, M.; Gross, C.; Surget, A.; Battaglia, F.; Dulawa, S.; Weisstaub, N.; Lee, J.; Duman, R.; Arancio, O.; et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003, 301, 805-809. [Cross Ref] [Pub Med]
181. Hong, J.G.; Kim, D.H.; Park, S.J.; Kim, J.M.; Cai, M.; Liu, X.; Lee, C.H.; Ryu, J.H. The memory-enhancing effects of Kami-ondam-tang in mice. J. Ethnopharmacol. 2011, 137, 251-256. [Cross Ref] [Pub Med]
182. Yang, W.M.; Shim, K.J.; Choi, M.J.; Park, S.Y.; Choi, B.J.; Chang, M.S.; Park, S.K. Novel effects of Nelumbo nucifera rhizome extract on memory and neurogenesis in the dentate gyrus of the rat hippocampus. Neurosci. Lett. 2008, 443, 104-107. [Cross Ref] [Pub Med]
183. Lee, C.H.; Kim, J.M.; Kim, D.H.; Park, S.J.; Liu, X.; Cai, M.; Hong, J.G.; Park, J.H.; Ryu, J.H. Effects of Sun ginseng on memory enhancement and hippocampal neurogenesis. Phytother. Res. 2013, 27, 1293-1299. [Cross Ref] [Pub Med]
184. Ahn, Y.J.; Park, S.J.;Woo, H.; Lee, H.E.; Kim, H.J.; Kwon, G.; Gao, Q.; Jang, D.S.; Ryu, J.H. Effects of allantoin on cognitive function and hippocampal neurogenesis. Food Chem. Toxicol. 2014, 64, 210-216. [Cross Ref] [Pub Med]
185. Deng, W.; Aimone, J.B.; Gage, F.H. New neurons and new memories: How does adult hippocampal neurogenesis affect learning and memory? Nat. Rev. Neurosci. 2010, 11, 339-350. [Cross Ref] [Pub Med]
186. Akers, K.G.; Martinez-Canabal, A.; Restivo, L.; Yiu, A.P.; de Cristofaro, A.; Hsiang, H.L.; Wheeler, A.L.; Guskjolen, A.; Niibori, Y.; Shoji, H.; et al. Hippocampal neurogenesis regulates forgetting during adulthood and infancy. Science 2014, 344, 598-602. [Cross Ref] [Pub Med]
187. Kaplan, D.R.; Miller, F.D. Neurotrophin signal transduction in the nervous system. Curr. Opin. Neurobiol. 2000, 10, 381-391. [Cross Ref]
188. Dudek, H.; Datta, S.R.; Franke, T.F.; Birnbaum, M.J.; Yao, R.; Cooper, G.M.; Segal, R.A.; Kaplan, D.R.; Greenberg, M.E. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 1997, 275, 661-665. [Cross Ref] [Pub Med]
189. Datta, S.R.; Dudek, H.; Tao, X.; Masters, S.; Fu, H.; Gotoh, Y.; Greenberg, M.E. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997, 91, 231-241. [Cross Ref]
190. Brunet, A.; Bonni, A.; Zigmond, M.J.; Lin, M.Z.; Juo, P.; Hu, L.S.; Anderson, M.J.; Arden, K.C.; Blenis, J.; Greenberg, M.E. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999, 96, 857-868. [Cross Ref]
191. Xia, Z.; Dickens, M.; Raingeaud, J.; Davis, R.J.; Greenberg, M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995, 270, 1326-1331. [Cross Ref] [Pub Med]
192. Lu, K.T.; Sun, C.L.; Wo, P.Y.; Yen, H.H.; Tang, T.H.; Ng, M.C.; Huang, M.L.; Yang, Y.L. Hippocampal neurogenesis after traumatic brain injury is mediated by vascular endothelial growth factor receptor-2 and the Raf/MEK/ERK cascade. J. Neurotrauma 2011, 28, 441-450. [Cross Ref] [Pub Med]
193. Ma, D.K.; Ponnusamy, K.; Song, M.R.; Ming, G.L.; Song, H. Molecular genetic analysis of FGFR1 signalling reveals distinct roles of MAPK and PLC1 activation for self-renewal of adult neural stem cells. Mol. Brain 2009, 2, 1-14. [Cross Ref] [Pub Med]
194. Cheng, A.; Hou, Y.; Mattson, M.P. Mitochondria and neuroplasticity. ASN Neuro 2010, 2, e00045. [Cross Ref] [Pub Med]
195. Wahane, S.D.; Hellbach, N.; Prentzell, M.T.; Weise, S.C.; Vezzali, R.; Kreutz, C.; Timmer, J.; Krieglstein, K.; Thedieck, K.; Vogel, T. PI3K-p110-α-subtype signalling mediates survival, proliferation and neurogenesis of cortical progenitor cells via activation of mTORC2. J. Neurochem. 2014, 130, 255-267. [Cross Ref] [Pub Med]
196. Fournier, N.M.; Lee, B.; Banasr, M.; Elsayed, M.; Duman, R.S. Vascular endothelial growth factor regulates adult hippocampal cell proliferation through MEK/ERK- and PI3K/Akt-dependent signaling. Neuropharmacology 2012, 63, 642-652. [Cross Ref] [Pub Med]
197. Chandran, A.; Iyo, A.H.; Jernigan, C.S.; Legutko, B.; Austin, M.C.; Karolewicz, B. Reduced phosphorylation of the mTOR signaling pathway components in the amygdala of rats exposed to chronic stress. Prog. Neuropsychopharmacol. Biol. Psychiatry 2013, 40, 240-245. [Cross Ref] [Pub Med]
198. Manning, B.D.; Cantley, L.C. AKT/PKB signaling: Navigating downstream. Cell 2007, 129, 1261-1274. [Cross Ref] [Pub Med]
199. Dibble, C.C.; Cantley, L.C. Regulation of mTORC1 by PI3K signaling. Trends Cell Biol. 2015, 25, 545-555. [Cross Ref] [Pub Med]
200. Sarbassov, D.D.; Ali, S.M.; Kim, D.H.; Guertin, D.A.; Latek, R.R.; Erdjument-Bromage, H.; Tempst, P.; Sabatini, D.M. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 2005, 307, 1098-1101. [Cross Ref] [Pub Med]
201. Sarbassov, D.D.; Ali, S.M.; Kim, D.H.; Guertin, D.A.; Latek, R.R.; Erdjument-Bromage, H.; Tempst, P.; Sabatini, D.M. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr. Biol. 2004, 14, 1296-1302. [Cross Ref] [Pub Med]
202. Hoeffer, C.A.; Klann, E. mTOR signaling: At the crossroads of plasticity, memory and disease. Trends Neurosci. 2010, 33, 67-75. [Cross Ref] [Pub Med]
203. Kelleher, R.J., III; Govindarajan, A.; Jung, H.Y.; Kang, H.; Tonegawa, S. Translational control by MAPK signaling in long-term synaptic plasticity and memory. Cell 2004, 116, 467-479. [Cross Ref]
204. Düvel, K.; Yecies, J.L.; Menon, S.; Raman, P.; Lipovsky, A.I.; Souza, A.L.; Triantafellow, E.; Ma, Q.; Gorski, R.; Cleaver, S.; et al. Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol. Cell 2010, 39, 171-183.
205. Aimone, J.B.; Wiles, J.; Gage, F.H. Potential role for adult neurogenesis in the encoding of time in new memories. Nat. Neurosci. 2006, 9, 723-727. [Cross Ref] [Pub Med]
206. Czéh, B.; Michaelis, T.;Watanabe, T.; Frahm, J.; de Biurrun, G.; van Kampen, M.; Bartolomucci, A.; Fuchs, E. Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc. Natl. Acad. Sci. USA 2001, 98, 12796-12801. [Cross Ref] [Pub Med]
207. Lesage, F.; Lazdunski, M. Molecular and functional properties of two-pore-domain potassium channels. Am. J. Physiol. Renal Physiol. 2000, 279, F793-F801. [Pub Med]
208. Zhao, G.; Etherton, T.D.; Martin, K.R.; Gillies, P.J.; West, S.G.; Kris-Etherton, P.M. Dietary α-linolenic acid inhibits proinflammatory cytokine production by peripheral blood monomuclear cells in hypercholesterolemic subjects. Am. J. Clin. Nutr. 2007, 85, 385-391. [Pub Med]
209. Mutoh, T.; Hamano, T.; Tokuda, A.; Kuriyama, M. Unglycosylated Trk protein does not co-localize nor associate with ganlioside GM1 in stable clone of PC12 cells overexpressing Trk (PCtrk cells). Glycoconj. J. 2000, 17, 233-237. [Cross Ref] [Pub Med]
210. Golub, T.; Wacha, S.; Caroni, P. Spatial and temporal control of signaling through lipid rafts. Curr. Opin. Neurobiol. 2004, 15, 542-550. [Cross Ref] [Pub Med]
211. Besshoh, S.; Chen, S.; Brown, I.R.; Gurd, J.W. Developmental changes in the association of NMDA receptors with lipid rafts. J. Neurosci. Res. 2007, 85, 1876-1883. [Cross Ref] [Pub Med]
212. Capone, C.; Frigerio, S.; Fumagalli, S.; Gelati, M.; Principato, M.C.; Storini, C.; Montinaro, M.; Kraftsik, R.; de Curtis, M.; Parati, E.; et al. Neurosphere-derived cells exert a neuroprotective action by changing the ischemic microenvironment. PLoS ONE 2007, 2, e373. [Cross Ref] [Pub Med]
213. Maysami, S.; Lan, J.Q.; Minami, M.; Simon, R.P. Proliferating progenitor cells: A required cellular element for induction of ischemic tolerance in the brain. J. Cereb. Blood Flow Metab. 2008, 28, 1104-1113. [Cross Ref] [Pub Med]
214. Nomura, T.; Honmou, O.; Harada, K.; Houkin, K.; Hamada, H.; Kocsis, J.D. I.V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Neuroscience 2005, 136, 161-169. [Cross Ref] [Pub Med]
215. Pallini, R.; Vitiani, L.R.; Bez, A.; Casalbore, P.; Facchiano, F.; di Giorgi Gerevini, V.; Falchetti, M.L.; Fernandez, E.; Maira, G.; Peschle, C.; et al. Homologous transplantation of neural stem cells to the injured spinal cord of mice. Neurosurgery 2005, 57, 1014-1025. [Cross Ref] [Pub Med]
216. 2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron 1998, 20, 709-726. [Cross Ref]
217. Marini, A.M.; Rabin, S.J.; Lipsky, R.H.; Mocchetti, I. Activity-dependent release of brain-derived neurotrophic factor underlies the neuroprotective effect of N-methyl-D-aspartate. J. Biol. Chem. 1998, 273, 29394-29399. [Cross Ref] [Pub Med]
218. Bernal, C.; Araya, C.; Palma, V.; Bronfman, M. PPARβ/Δ and PPARγ maintain undifferentiated phenotypes of mouse adult neural precursor cells from the subventricular zone. Front Cell Neurosci. 2015, 9, 78. [Cross Ref] [Pub Med]
219. Ramanan, S.; Kooshki, M.; Zhao, W.; Hsu, F.C.; Robbins, M.E. PPARα ligands inhibit radiation-induced microglial inflammatory responses by negatively regulating NF-κB and AP-1 pathways. Free Radic. Biol. Med. 2008, 45, 1695-1704. [Cross Ref] [Pub Med]
220. Lecca, D.; Nevin, D.K.; Mulas, G.; Casu, M.A.; Diana, A.; Rossi, D.; Sacchetti, G.; Carta, A.R. Neuroprotective and anti-inflammatory properties of a novel non-thiazolidinedione PPAR agonist in vitro and in MPTP-treated mice. Neuroscience 2015, 302, 23-35. [Cross Ref] [Pub Med]
221. Calder, P.C. Mechanisms of action of (n-3) fatty acids. J. Nutr. 2012, 142, 592S-599S. [Cross Ref] [Pub Med]